SCALISE, MARIAFRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 4.913
AS - Asia 4.117
EU - Europa 2.722
SA - Sud America 1.142
AF - Africa 332
Continente sconosciuto - Info sul continente non disponibili 223
OC - Oceania 13
Totale 13.462
Nazione #
US - Stati Uniti d'America 4.677
SG - Singapore 1.581
IT - Italia 846
BR - Brasile 783
CN - Cina 736
VN - Vietnam 623
DE - Germania 511
UA - Ucraina 511
FR - Francia 267
BD - Bangladesh 261
HK - Hong Kong 199
SN - Senegal 182
IN - India 135
SE - Svezia 130
AR - Argentina 126
CA - Canada 113
FI - Finlandia 99
TR - Turchia 89
KR - Corea 85
AT - Austria 69
MX - Messico 65
GB - Regno Unito 64
IQ - Iraq 63
ID - Indonesia 56
EC - Ecuador 55
PK - Pakistan 50
CO - Colombia 41
RU - Federazione Russa 41
ZA - Sudafrica 38
VE - Venezuela 31
JP - Giappone 29
CL - Cile 28
SA - Arabia Saudita 27
ES - Italia 26
MA - Marocco 25
BE - Belgio 24
NL - Olanda 24
PE - Perù 24
PL - Polonia 24
UZ - Uzbekistan 24
MY - Malesia 21
PH - Filippine 20
TN - Tunisia 18
BO - Bolivia 17
PY - Paraguay 17
UY - Uruguay 17
DZ - Algeria 15
EG - Egitto 15
NP - Nepal 13
KZ - Kazakistan 12
AE - Emirati Arabi Uniti 11
AZ - Azerbaigian 11
AU - Australia 10
DO - Repubblica Dominicana 9
TH - Thailandia 9
CR - Costa Rica 8
JO - Giordania 8
LB - Libano 8
NI - Nicaragua 8
BG - Bulgaria 7
CZ - Repubblica Ceca 7
HU - Ungheria 7
KE - Kenya 7
NG - Nigeria 7
RO - Romania 7
BY - Bielorussia 6
IE - Irlanda 6
JM - Giamaica 6
SK - Slovacchia (Repubblica Slovacca) 6
AL - Albania 5
CI - Costa d'Avorio 5
EU - Europa 5
HN - Honduras 5
MN - Mongolia 5
OM - Oman 5
PA - Panama 5
RS - Serbia 5
AM - Armenia 4
CH - Svizzera 4
ET - Etiopia 4
GT - Guatemala 4
PS - Palestinian Territory 4
PT - Portogallo 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
GA - Gabon 3
IL - Israele 3
IR - Iran 3
KG - Kirghizistan 3
KH - Cambogia 3
LT - Lituania 3
LY - Libia 3
MD - Moldavia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
DK - Danimarca 2
GY - Guiana 2
HR - Croazia 2
KW - Kuwait 2
Totale 13.205
Città #
Singapore 694
Chandler 455
San Jose 426
Council Bluffs 349
Ashburn 305
Jacksonville 289
Dallas 250
Ho Chi Minh City 217
Boardman 196
Hong Kong 188
Beijing 187
Dakar 181
San Mateo 177
New York 166
Dearborn 132
Hanoi 128
Munich 121
Santa Clara 115
Redmond 111
Lauterbourg 91
Milan 91
Shanghai 88
Seoul 84
Lawrence 80
Roxbury 80
Los Angeles 78
Bremen 76
Rende 72
Rome 71
São Paulo 71
Hefei 61
Helsinki 61
Ann Arbor 60
Columbus 58
Izmir 58
Cosenza 55
Des Moines 55
Vienna 51
Ottawa 50
Inglewood 47
The Dalles 45
Florence 41
Brooklyn 40
Da Nang 38
Ogden 33
Turku 32
Haiphong 31
Naples 31
Orem 28
Wilmington 28
Secaucus 27
Baghdad 26
Pune 26
Rio de Janeiro 26
Mumbai 25
Seattle 25
Tokyo 25
Buffalo 24
Jakarta 24
Toronto 24
Brussels 23
Guangzhou 23
London 22
Falkenstein 21
Frankfurt am Main 21
Mexico City 21
Dhaka 20
Tashkent 19
Warsaw 19
San Francisco 18
Cambridge 17
Buenos Aires 16
Chennai 16
Chicago 16
Guayaquil 16
Johannesburg 16
Quito 16
Biên Hòa 15
Lima 15
Curitiba 14
Grafing 14
Salvador 14
Bari 13
Belo Horizonte 13
Bologna 13
Brasília 13
Catania 13
Figino 13
Guarulhos 13
Montreal 13
Philadelphia 13
Kuala Lumpur 12
Lahore 12
Tampa 12
Asunción 11
Manchester 11
Nanjing 11
Omaha 11
Phoenix 11
Redwood City 11
Totale 7.335
Nome #
LAT1 is the transport competent unit of the LAT1/CD98 heterodimeric amino acid transporter 316
Studying interactions of drugs with cell membrane nutrient transporters: New frontiers of proteoliposome nanotechnology 271
The Human SLC1A5 (ASCT2) amino acid transporter: From function to structure and role in cell biology 232
Cys site-directed mutagenesis of the human SLC1A5 (ASCT2) transporter: Structure/function relationships and crucial role of Cys467 for redox sensing and glutamine transport 213
ATP modulates SLC7A5 (LAT1) synergistically with cholesterol 213
Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods 207
Insights into the transport side of the human SLC38A9 transceptor 207
Characterization of the CAT2 transporter from Solanum lycopersicum (Tomato). 201
Regulatory Aspects of the Vacuolar CAT2 Arginine Transporter of S. lycopersicum: Role of Osmotic Pressure and Cations 193
Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter 191
Carnitine Traffic in Cells. Link With Cancer 191
Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for Drugs 186
Cysteine is not a substrate but a specific modulator of human ASCT2 (SLC1A5) transporter. 184
Glutamine transport and mitochondrial metabolism in cancer cell growth 184
Bacterial production and reconstitution in proteoliposomes of Solanum lycopersicum CAT2: a transporter of basic amino acids and organic cations 179
Cloning, Large Scale Over-Expression in E-coli and Purification of the Components of the Human LAT 1 (SLC7A5) Amino Acid Transporter 176
Functional and Molecular Effects of Mercury Compounds on the Human OCTN1 Cation Transporter: C50 and C136 Are the Targets for Potent Inhibition 172
A targetable antioxidant defense mechanism to EZH2 inhibitors enhances tumor cell vulnerability to ferroptosis 170
Chemical Targeting of Membrane Transporters: Insights into Structure/Function Relationships 170
Acetylcholine and acetylcarnitine transport in peritoneum: Role of the SLC22A4 (OCTN1) transporter 165
Effect of cholesterol on the organic cation transporter OCTN1 (SLC22A4) 165
Bacterial over-expression of functionally active human CT2 (SLC22A16) carnitine transporter 161
Carnitine traffic and human fertility 157
Over-Expression in E. coli and Purification of the Human OCTN2 Transport Protein 157
Mitochondrial Carnitine/Acylcarnitine Transporter, a Novel Target of Mercury Toxicity 157
ASCT1 and ASCT2: Brother and Sister? 157
Cysteine 467 of the ASCT2 Amino Acid Transporter Is a Molecular Determinant of the Antiport Mechanism 157
Chemical approaches for studying the biology and pharmacology of membrane transporters: The histidine/large amino acid transporter slc7a5 as a benchmark 156
The human SLC7A5 (LAT1): The intriguing histidine/large neutral amino acid transporter and its relevance to human health 155
OCTN Cation Transporters in Health and Disease: Role as Drug Targets and Assay Development 151
Amino acids transport and metabolism 2.0 151
Exosomes in inflammation and role as biomarkers 150
Interaction of Cholesterol With the Human SLC1A5 (ASCT2): Insights Into Structure/Function Relationships 146
The Human SLC1A5 Neutral Amino Acid Transporter Catalyzes a pH-Dependent Glutamate/Glutamine Antiport, as Well 146
Inhibition of the carnitine acylcarnitine carrier by carbon monoxide reveals a novel mechanism of action with non-metal-containing proteins 144
Immuno-detection of OCTN1 (SLC22A4) in He La cells and characterization of transport function 144
Glutamine transport. From energy supply to sensing and beyond 144
Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health 143
Strategies of Bacterial Over Expression of Membrane Transporters Relevant in Human Health: The Successful Case of the Three Members of OCTN Subfamily 140
Human OCTN2 (SLC22A5) is down-regulated in virus- and nonvirus-mediated cancer 139
Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5). Probing critical residues for substrate translocation 139
The involvement of sodium in the function of the human amino acid transporter ASCT2 136
The Nutraceutical Alliin From Garlic Is a Novel Substrate of the Essential Amino Acid Transporter LAT1 (SLC7A5) 132
Potent inhibitors of human LAT1 (SLC7A5) transporter based on dithiazole and dithiazine compounds for development of anticancer drugs 131
Functional and kinetic characterization of the acetylcholine transport catalized by the recombinant human OCTN1 transporter reconstituted in liposomes. 129
Reconstitution in liposomes of the functionally active human OCTN1 (SLC22A4) transporter overexpressed in Escherichia coli 127
Glutamine transporters as pharmacological targets: From function to drug design 127
Large scale production of the active human ASCT2 (SLC1A5) transporter in Pichia pastoris - functional and kinetic asymmetry revealed in proteoliposomes 126
Over-expression in Escherichia coli, purification and reconstitution in liposomes of the third member of the OCTN sub-family: The mouse carnitine transporter OCTN3 124
Site directed mutanesis of Cys residues of the human OCTN1 transporter 123
Membrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring 122
OCTN: A Small Transporter Subfamily with Great Relevance to Human Pathophysiology, Drug Discovery, and Diagnostics 122
Repurposing Nimesulide, a Potent Inhibitor of the B0AT1 Subunit of the SARS-CoV-2 Receptor, as a Therapeutic Adjuvant of COVID-19 122
N-linked Glycosylation of human SLC1A5 (ASCT2) transporter is critical for trafficking to membrane 121
Transport mechanism and regulatory properties of the human amino acid transporter ASCT2 (SLC1A5) 119
Cholesterol stimulates the cellular uptake of L-carnitine by the carnitine/organic cation transporter novel 2 (OCTN2) 119
Inactivation by omeprazole of the carnitine transporter (OCTN2) reconstituted in liposomes 118
Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder 118
The Sodium Sialic acid symporter from Staphylococcus aureus has altered substrate specificity 116
SLC1A5 (solute carrier family 1 (neutral amino acid transporter), member 5 116
The human OCTN1 (SLC22A4) reconstituted in liposomes catalyzes acetylcholine transport which is defective in the mutant L503F associated to the Crohn's disease 114
N-glycosylation is crucial for trafficking and stability of SLC3A2 (CD98) 111
OCTN1 (SLC22A4) displays two different transport pathways for organic cations or zwitterions 111
Using liposomes to functionally characterize transport systems for glutamine and neutral amino acids 111
OCTN1: A Widely Studied but Still Enigmatic Organic Cation Transporter Linked to Human Pathology and Drug Interactions 111
Production of recombinant human xCT (SLC7A11) and reconstitution in proteoliposomes for functional studies 110
OCTN1 (SLC22A4) as a Target of Heavy Metals: Its Possible Role in Microplastic Threats 109
Strategies for bacterial over-expression of the canonical and variant hOCTN2 transport proteins. 108
Extracellular Vesicles and Cell Pathways Involved in Cancer Chemoresistance 107
Substrate-bound outward-open structure of a Na+-coupled sialic acid symporter reveals a new Na+site 106
Strategies for bacterial expression and large scale purification of human amino acid transporters. 105
The yeast P-pastoris as a tool for large scale production of WT and mutant human amino acid transporter SLC1A5 104
Regulation by physiological cations of acetylcholine transport mediated by human OCTN1 (SLC22A4). Implications in the non-neuronal cholinergic system. 103
Over-expression and purification of the human OCTN1 and OCTN2 transporters in detergent soluble form 102
Editorial: Transport of Nutrients, Metabolites and Ions Linked to Bioenergetics: Relevance to Human Pathology 98
Nimesulide binding site in the B0AT1 (SLC6A19) amino acid transporter. Mechanism of inhibition revealed by proteoliposome transport assay and molecular modelling 96
Strategies for Successful Over-Expression of Human Membrane Transport Systems Using Bacterial Hosts: Future Perspectives 96
Over-Production of the Human SLC7A10 in E. coli and Functional Assay in Proteoliposomes 94
Strategies of large scale expression and purification of the transport proteins OCTN1 and OCTN2. 94
Inhibition of the Mitochondrial Carnitine/Acylcarnitine Carrier by Itaconate through Irreversible Binding to Cysteine 136: Possible Pathophysiological Implications 90
TMBIM5 is the Ca2+ /H+ antiporter of mammalian mitochondria 88
NEW INSIGHTS IN FUNCTIONAL PROPERTIES OF THE HUMAN OCTN1 TRANSPORTER: IMPLICATION IN CROHN'S DISEASE 88
Strategies of expression of the tran sport proteins OCTN1 and OCTN2 88
Over-expression in E. coli of the mouse OCTN3 (SLC22A21) transporter 87
Proteoliposomes as tool for assaying membrane transporter functions and interactions with xenobiotics 87
Human OCTN1 transporter as a target for heavy metals: molecular mechanism of interaction. Congresso scientifico Non neuronal cholinergic system, Justus-Liebig-University Giessen 87
IκB kinase β promotes cell survival by Antagonizing p53 functions through ΔNp73α phosphorylation and stabilization 87
LAT1 (SLC7A5) catalyzes copper(histidinate) transport switching from antiport to uniport mechanism 86
The Link Between the Mitochondrial Fatty Acid Oxidation Derangement and Kidney Injury 86
Human papillomavirus type 38 alters wild-type p53 activity to promote cell proliferation via the downregulation of integrin alpha 1 expression 84
The recombinant human OCTN1 transporter catalyses acetylcholine transport in reconstituted liposomes 82
Over-expression in E. coli and reconstitution in liposomes of the OCTN3 (SLC22A21) transporter. 81
Lysine 204 is crucial for the antiport function of the human LAT1 transporter 80
OCTN1 mediates acetylcholine transport in the A549 lung cancer cells: possible pathophysiological implications 77
Sialic Acid Derivatives Inhibit SiaT Transporters and Delay Bacterial Growth 76
Novel functional and structural properties of the human OCTN1 transporter: implication in pathophysiology 71
Structure and mechanism of a tripartite ATP-independent periplasmic TRAP transporter 66
Inflammation and Organic Cation Transporters Novel (OCTNs) 63
Editorial: Transport of Nutrients, Metabolites and Ions linked to Bioenergetics: Relevance to Human Pathology, Volume II 60
Production of the human carnitine transporter CT2 (SLC22A16) by bacterial expression and functional characterization in proteoliposomes 56
Totale 13.188
Categoria #
all - tutte 69.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022803 0 0 13 48 88 22 8 214 18 8 143 241
2022/20231.191 131 169 24 148 180 95 13 168 129 22 77 35
2023/2024724 59 41 48 30 57 145 33 51 58 38 40 124
2024/20251.938 79 218 62 97 166 175 131 127 203 105 214 361
2025/20266.165 660 223 498 391 1.065 508 763 303 532 400 459 363
2026/2027809 410 279 120 0 0 0 0 0 0 0 0 0
Totale 13.462